Furlan M, Perret B A, Beck E A
Thromb Haemost. 1981 Jun 30;45(3):242-6.
Human factor VIII/von Willebrand protein is a population of multimers which vary in size but contain apparently identical subunits. Large-molecular-weight forms possess higher ristocetin cofactor/von Willebrand activity than the native smaller oligomers. Disulfide reduction of large factor VIII multimers results in progressively decreasing molecular size and a loss of ristocetin cofactor activity. Small molecular forms of factor VIII were adsorbed onto gold granules (average diameter 20-30 nm) and thereby increased their ristocetin cofactor activity. The amount of adsorbed material and the extent of activation were dependent on the pH of the coiled suspension. The maximum recovery of von Willebrand activity was observed at pH 4.75. Aggregation of fixed human platelets by factor VIII-coated gold particles was dependent on ristocetin concentration and was not competitively inhibited by unbound low-molecular-weight factor VIII. These results suggest that the subunits of the native small factor VIII species possess potential binding affinity for platelet receptors, which is manifested following formation of large factor VIII polymers. We conclude that an optimal size of remarkably high molecular weight is required for efficient aggregation of platelets by factor VIII as occurs during the primary phase of hemostasis.
人凝血因子VIII/血管性血友病因子是一群大小各异但亚基明显相同的多聚体。大分子形式的血管性血友病因子活性比天然的较小寡聚体具有更高的瑞斯托霉素辅因子/血管性血友病因子活性。大分子凝血因子VIII多聚体的二硫键还原会导致分子大小逐渐减小以及瑞斯托霉素辅因子活性丧失。小分子形式的凝血因子VIII吸附到金颗粒(平均直径20 - 30纳米)上,从而提高了它们的瑞斯托霉素辅因子活性。吸附物质的量和活化程度取决于卷曲悬浮液的pH值。在pH 4.75时观察到血管性血友病因子活性的最大恢复。凝血因子VIII包被的金颗粒对固定人血小板的聚集取决于瑞斯托霉素浓度,且不受未结合的低分子量凝血因子VIII的竞争性抑制。这些结果表明,天然小凝血因子VIII亚基对血小板受体具有潜在的结合亲和力,这种亲和力在大凝血因子VIII聚合物形成后得以体现。我们得出结论,在止血的初级阶段,凝血因子VIII有效聚集血小板需要极高分子量的最佳大小。